BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31351063)

  • 1. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
    Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
    Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).
    Janardhanan P; Somasundaran AK; Balakrishnan AJ; Pilankatta R
    Cancer Treat Res Commun; 2022; 32():100613. PubMed ID: 35908410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Activation of Cell-Cycle-Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma.
    Yoshida K; Yokoi A; Yamamoto T; Hayashi Y; Nakayama J; Yokoi T; Yoshida H; Kato T; Kajiyama H; Yamamoto Y
    Clin Cancer Res; 2022 May; 28(10):2147-2159. PubMed ID: 35302600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
    Matsuzaki S; Enomoto T; Serada S; Yoshino K; Nagamori S; Morimoto A; Yokoyama T; Kim A; Kimura T; Ueda Y; Fujita M; Fujimoto M; Kanai Y; Kimura T; Naka T
    Int J Cancer; 2014 Apr; 134(8):1796-809. PubMed ID: 24150977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
    Komatsu M; Sumizawa T; Mutoh M; Chen ZS; Terada K; Furukawa T; Yang XL; Gao H; Miura N; Sugiyama T; Akiyama S
    Cancer Res; 2000 Mar; 60(5):1312-6. PubMed ID: 10728692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.
    Eskander RN; Randall LM; Sakai T; Guo Y; Hoang B; Zi X
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1086-94. PubMed ID: 22540374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells.
    Li B; Takeda T; Tsuiji K; Wong TF; Tadakawa M; Kondo A; Nagase S; Yaegashi N
    Int J Gynecol Cancer; 2013 Jun; 23(5):803-8. PubMed ID: 23532091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model.
    Garcia N; Ulin M; Ali M; Al-Hendy A; Carvalho KC; Yang Q
    Reprod Sci; 2022 Mar; 29(3):781-790. PubMed ID: 34642915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).
    Song L; Li Y; Li W; Wu S; Li Z
    J Cell Biochem; 2014 Jul; 115(7):1234-42. PubMed ID: 24038379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
    Dmitriev OY
    Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
    Ryumon S; Okui T; Kunisada Y; Kishimoto K; Shimo T; Hasegawa K; Ibaragi S; Akiyama K; Thu Ha NT; Monsur Hassan NM; Sasaki A
    Oncol Rep; 2019 Dec; 42(6):2611-2621. PubMed ID: 31638244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of copper transporters in cisplatin resistance.
    Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
    Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule-stabilizing effect.
    Yu H; Wang H; Qie A; Wang J; Liu Y; Gu G; Yang J; Zhang H; Pan W; Tian Z; Wang C
    Cancer Sci; 2021 Nov; 112(11):4655-4668. PubMed ID: 34533854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.
    Vyas A; Duvvuri U; Kiselyov K
    Biochem J; 2019 Dec; 476(24):3705-3719. PubMed ID: 31790150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines.
    Nakayama K; Miyazaki K; Kanzaki A; Fukumoto M; Takebayashi Y
    Oncol Rep; 2001; 8(6):1285-7. PubMed ID: 11605050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma.
    Zeng X; Baba T; Hamanishi J; Matsumura N; Kharma B; Mise Y; Abiko K; Yamaguchi K; Horikawa N; Hunstman DG; Mulati K; Kitamura S; Taki M; Murakami R; Hosoe Y; Mandai M
    Int J Cancer; 2019 Sep; 145(6):1635-1647. PubMed ID: 31228268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein.
    Fang T; Chen W; Sheng Y; Yuan S; Tang Q; Li G; Huang G; Su J; Zhang X; Zang J; Liu Y
    Nat Commun; 2019 Jan; 10(1):186. PubMed ID: 30643139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.